13
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Human gut-microbiome-derived propionate coordinates proteasomal degradation via HECTD2 upregulation to target EHMT2 in colorectal cancer

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The human microbiome plays an essential role in the human immune system, food digestion, and protection from harmful bacteria by colonizing the human intestine. Recently, although the human microbiome affects colorectal cancer (CRC) treatment, the mode of action between the microbiome and CRC remains unclear. This study showed that propionate suppressed CRC growth by promoting the proteasomal degradation of euchromatic histone-lysine N-methyltransferase 2 (EHMT2) through HECT domain E3 ubiquitin protein ligase 2 (HECTD2) upregulation. In addition, EHMT2 downregulation reduced the H3K9me2 level on the promoter region of tumor necrosis factor α-induced protein 1 (TNFAIP1) as a novel direct target of EHMT2. Subsequently, TNFAIP1 upregulation induced the apoptosis of CRC cells. Furthermore, using Bacteroides thetaiotaomicron culture medium, we confirmed EHMT2 downregulation via upregulation of HECTD2 and TNFAIP1 upregulation. Finally, we observed the synergistic effect of propionate and an EHMT2 inhibitor (BIX01294) in 3D spheroid culture models. Thus, we suggest the anticancer effects of propionate and EHMT2 as therapeutic targets for colon cancer treatment and may provide the possibility for the synergistic effects of an EHMT2 inhibitor and microbiome in CRC treatment.

          Related collections

          Most cited references46

          • Record: found
          • Abstract: found
          • Article: not found

          From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites.

          A compelling set of links between the composition of the gut microbiota, the host diet, and host physiology has emerged. Do these links reflect cause-and-effect relationships, and what might be their mechanistic basis? A growing body of work implicates microbially produced metabolites as crucial executors of diet-based microbial influence on the host. Here, we will review data supporting the diverse functional roles carried out by a major class of bacterial metabolites, the short-chain fatty acids (SCFAs). SCFAs can directly activate G-coupled-receptors, inhibit histone deacetylases, and serve as energy substrates. They thus affect various physiological processes and may contribute to health and disease.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Human organoids: model systems for human biology and medicine

            The historical reliance of biological research on the use of animal models has sometimes made it challenging to address questions that are specific to the understanding of human biology and disease. But with the advent of human organoids — which are stem cell-derived 3D culture systems — it is now possible to re-create the architecture and physiology of human organs in remarkable detail. Human organoids provide unique opportunities for the study of human disease and complement animal models. Human organoids have been used to study infectious diseases, genetic disorders and cancers through the genetic engineering of human stem cells, as well as directly when organoids are generated from patient biopsy samples. This Review discusses the applications, advantages and disadvantages of human organoids as models of development and disease and outlines the challenges that have to be overcome for organoids to be able to substantially reduce the need for animal experiments.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The role of short-chain fatty acids in health and disease.

              There is now an abundance of evidence to show that short-chain fatty acids (SCFAs) play an important role in the maintenance of health and the development of disease. SCFAs are a subset of fatty acids that are produced by the gut microbiota during the fermentation of partially and nondigestible polysaccharides. The highest levels of SCFAs are found in the proximal colon, where they are used locally by enterocytes or transported across the gut epithelium into the bloodstream. Two major SCFA signaling mechanisms have been identified, inhibition of histone deacetylases (HDACs) and activation of G-protein-coupled receptors (GPCRs). Since HDACs regulate gene expression, inhibition of HDACs has a vast array of downstream consequences. Our understanding of SCFA-mediated inhibition of HDACs is still in its infancy. GPCRs, particularly GPR43, GPR41, and GPR109A, have been identified as receptors for SCFAs. Studies have implicated a major role for these GPCRs in the regulation of metabolism, inflammation, and disease. SCFAs have been shown to alter chemotaxis and phagocytosis; induce reactive oxygen species (ROS); change cell proliferation and function; have anti-inflammatory, antitumorigenic, and antimicrobial effects; and alter gut integrity. These findings highlight the role of SCFAs as a major player in maintenance of gut and immune homeostasis. Given the vast effects of SCFAs, and that their levels are regulated by diet, they provide a new basis to explain the increased prevalence of inflammatory disease in Westernized countries, as highlighted in this chapter.
                Bookmark

                Author and article information

                Contributors
                dspark@kribb.re.kr
                kds2465@kribb.re.kr
                myson@kribb.re.kr
                chohs@kribb.re.kr
                Journal
                ISME J
                ISME J
                The ISME Journal
                Nature Publishing Group UK (London )
                1751-7362
                1751-7370
                1 January 2022
                1 January 2022
                May 2022
                : 16
                : 5
                : 1205-1221
                Affiliations
                [1 ]GRID grid.249967.7, ISNI 0000 0004 0636 3099, Korea Research Institute of Bioscience and Biotechnology, ; Daejeon, 34141 Republic of Korea
                [2 ]GRID grid.37172.30, ISNI 0000 0001 2292 0500, Department of Biological Sciences, , Korea Advanced Institute of Science and Technology (KAIST), ; Daejeon, 34141 Republic of Korea
                [3 ]GRID grid.412786.e, ISNI 0000 0004 1791 8264, Korea University of Science and Technology, ; Daejeon, 34113 Republic of Korea
                [4 ]GRID grid.267370.7, ISNI 0000 0004 0533 4667, Asan Institute for Life Sciences, Asan Medical Center and Department of Convergence Medicine, College of Medicine, , University of Ulsan, ; Seoul, 05505 Republic of Korea
                [5 ]GRID grid.258803.4, ISNI 0000 0001 0661 1556, Department of Biochemistry and Cell biology, School of Medicine, , Kyungpook National University, ; Daegu, 41944 Republic of Korea
                [6 ]GRID grid.272242.3, ISNI 0000 0001 2168 5385, Division of Molecular Modification and Cancer Biology, , National Cancer Center, ; Tokyo, 104-0045 Japan
                Author information
                http://orcid.org/0000-0003-4528-6789
                http://orcid.org/0000-0002-4999-1613
                http://orcid.org/0000-0001-7590-8812
                http://orcid.org/0000-0002-8242-9390
                Article
                1119
                10.1038/s41396-021-01119-1
                9038766
                34972816
                6159c372-8e98-4de6-92f3-86a61c600740
                © The Author(s) 2021

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 15 September 2020
                : 8 September 2021
                : 14 September 2021
                Categories
                Article
                Custom metadata
                © International Society for Microbial Ecology 2022

                Microbiology & Virology
                colorectal cancer,transcriptomics,functional genomics
                Microbiology & Virology
                colorectal cancer, transcriptomics, functional genomics

                Comments

                Comment on this article